Ind Swift Laboratories Share Price | Ind Swift Laboratories Stock Screener
INDSWFTLAB
Pharmaceuticals
Share Price NSE
₹134.83
▼
-1.34 (-0.98%)
Share Price BSE
₹134.85
▼
-1.15 (-0.85%)
As of May 27, 2026, the Ind Swift Laboratories share price (NSE: INDSWFTLAB) is ₹134.83 on NSE and ₹134.85 on BSE, down 0.98% from the previous close, with shares trading between ₹133.30 and ₹138.28, and a 52-week range of ₹88.15–₹150.28.
Check INDSWFTLAB 52-week high low for the annual price range and momentum.
Use the Ind Swift Laboratories stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Ind Swift Laboratories Market Cap
₹1,146.15 Cr.
INDSWFTLAB P/E Ratio (TTM)
4.61
Ind Swift Laboratories P/B Ratio
0.84
EPS (TTM)
₹37.25
Dividend Yield
-
Debt to Equity
0.11
INDSWFTLAB 52 Week High
₹150.28
Ind Swift Laboratories 52 Week Low
₹88.15
Operating Margin
-1.00%
Profit Margin
5.62%
INDSWFTLAB Revenue (TTM)
₹178.00
EBITDA
₹26.00
Net Income
₹10.00
Total Assets
₹1,438.00
Total Equity
₹1,173.00
Ind Swift Laboratories Share Price Chart
Screen Ind Swift Laboratories share price with an interactive chart. Analyse INDSWFTLAB price trends and volatility across different timeframes.
Ind Swift Laboratories Company Profile - Fundamental Screener
Screen Ind Swift Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for INDSWFTLAB shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE915B01019
Ind Swift Laboratories Balance Sheet Screener
Screen INDSWFTLAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 1,438 | 1,460 | 1,824 | 1,801 | 1,818 | 1,870 | 1,924 | 2,023 | 2,138 | 2,215 |
| Current Assets | 865 | 960 | 1,165 | 1,075 | 944 | 863 | 836 | 842 | 832 | 926 |
| Fixed Assets | 273 | 192 | 588 | 630 | 753 | 843 | 914 | 934 | 1,042 | 1,099 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 45 | 215 | 771 | 866 | 901 | 906 | 980 | 534 | 601 | 746 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 1,173 | 812 | 682 | 601 | 603 | 641 | 588 | 553 | 531 | 517 |
| Share Capital | 69 | 67 | 60 | 60 | 60 | 60 | 48 | 46 | 46 | 42 |
| Reserves & Surplus | 1,030 | 745 | 622 | 541 | 544 | 581 | 540 | 507 | 486 | 476 |
Ind Swift Laboratories Income Statement Screener - Profit & Revenue Analysis
Screen Ind Swift Laboratories income statement and profit fundamentals.
Analyze INDSWFTLAB quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Ind Swift Laboratories share price evaluation.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept | 2022-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 178 | 171 | 167 | 359 | 145 | 25 | 44 | 987 | 295 | 297 | 316 | 315 | 321 | 318 | 288 |
| Expenses | 153 | 151 | 149 | 147 | 136 | 24 | 43 | 437 | 236 | 224 | 250 | 267 | 259 | 252 | 227 |
| EBITDA | 26 | 19 | 18 | 211 | 9 | 1 | 1 | 549 | 59 | 73 | 66 | 47 | 62 | 66 | 60 |
| Operating Profit % | -1.00% | 1.00% | 2.00% | -7.00% | -6.00% | -99.00% | -29.00% | 17.00% | 18.00% | 23.00% | 19.00% | 12.00% | 17.00% | 19.00% | 19.00% |
| Depreciation | 9 | 7 | 7 | 7 | 6 | 0 | 0 | 20 | 14 | 13 | 14 | 9 | 15 | 16 | 16 |
| Interest | 1 | 2 | 1 | -27 | 10 | 0 | 0 | 3 | 21 | 21 | 20 | 22 | 22 | 24 | 24 |
| Profit Before Tax | 16 | 10 | 10 | 231 | -7 | 1 | 1 | 527 | 24 | 39 | 32 | 16 | 24 | 26 | 20 |
| Tax | 7 | 2 | 2 | 8 | -1 | 0 | 0 | 33 | 5 | 7 | 14 | 41 | -3 | 1 | 0 |
| Net Profit | 10 | 8 | 9 | 222 | -6 | 0 | 1 | 494 | 19 | 32 | 17 | -25 | 28 | 25 | 20 |
| EPS | 1.17 | 1.00 | 1.28 | 32.96 | -0.82 | 0.07 | 0.16 | 83.55 | 3.29 | 5.36 | 2.92 | -4.25 | 4.65 | 4.29 | 3.36 |
Ind Swift Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen INDSWFTLAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -26 | -187 | 195 | 150 | 135 | 125 | -64 | 73 | 96 | 79 |
| Investing Activities | -110 | -28 | -13 | 5 | -10 | -9 | -13 | -17 | -31 | -29 |
| Financing Activities | 69 | 657 | -186 | -141 | -124 | -133 | 100 | -62 | -69 | -48 |
| Net Cash Flow | -67 | 443 | -4 | 14 | 1 | -17 | 23 | -6 | -4 | 3 |
Ind Swift Laboratories Shareholding Pattern Screener
See Ind Swift Laboratories shareholding pattern with promoter, FII, and DII holdings.
Check Ind Swift Laboratories promoter holding and ownership changes for INDSWFTLAB on TickJournal.
| Item | 2026-Feb | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Jul | 2025-Aug | 2025-Sept | 2025-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 43.06% | 42.99% | 40.94% | 40.94% | 36.77% | 39.50% | 39.50% | 39.50% |
| FII Holding | 13.80% | 13.88% | 3.07% | 4.27% | 0.00% | 0.00% | 14.80% | 14.33% |
| DII Holding | 0.16% | 0.00% | 0.91% | 0.91% | 0.00% | 0.00% | 0.68% | 0.68% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 32.97% | 32.90% | 37.61% | 41.36% | 35.11% | 34.75% | 34.96% | 35.06% |
| Other Holding | 10.01% | 10.22% | 17.46% | 12.51% | 28.12% | 25.76% | 10.06% | 10.43% |
| Shareholder Count | 40,404 | 39,222 | 28,190 | 28,709 | 28,539 | 28,892 | 43,780 | 42,121 |
Ind Swift Laboratories Share Dividend Screener - Share Yield Analysis
Check Ind Swift Laboratories dividend history with payout and yield data.
View Ind Swift Laboratories dividend details including ex-dates and amounts for INDSWFTLAB stock.
Ind Swift Laboratories Stock Index Membership
See which indices include Ind Swift Laboratories stock.
Check INDSWFTLAB index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Ind Swift Laboratories Market Events Screener - Corporate Actions
Get Ind Swift Laboratories corporate actions including splits, bonuses, and buybacks.
Check Ind Swift Laboratories stock events that may affect INDSWFTLAB share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -11.61% | ||
| Annual General Meeting | NA | 1.99% | ||
| 2026-05-28 | 2026-05-28 | Quarterly Result Announcement | NA | -2.84% |
| 2026-01-31 | 2026-01-31 | Quarterly Result Announcement | NA | 6.25% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 1.83% |
| 2025-08-14 | 2025-08-14 | Merger - Demerger | 100:15 | 0.00% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | -1.61% |
| 2025-08-11 | 2025-08-11 | Quarterly Result Announcement | NA | -4.59% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 7.93% |
| 2025-02-22 | 2025-02-22 | Extraordinary General Meeting | NA | -12.05% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -11.38% |
| 2024-11-11 | 2024-11-11 | Quarterly Result Announcement | NA | -2.34% |
| 2024-07-22 | 2024-07-22 | Extraordinary General Meeting | NA | 2.12% |
| 2023-10-06 | 2023-10-06 | Extraordinary General Meeting | NA | -12.80% |
Ind Swift Laboratories Competitors Screener - Peer Comparison
Screen INDSWFTLAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 441,622 | 40.42 | 58,220 | 6.38% | 11,565 | 54.03 |
| Divis Laboratories | 179,364 | 73.73 | 10,560 | 8.73% | 2,520 | 57.30 |
| Torrent Pharmaceuticals | 154,758 | 66.80 | 13,753 | 19.18% | 2,028 | 66.36 |
| Cipla | 114,212 | 29.26 | 27,712 | -2.46% | 3,783 | 64.19 |
| Dr Reddys Laboratories | 111,124 | 26.24 | 33,593 | -0.44% | 3,998 | 57.44 |
| Zydus Life Science | 107,964 | 20.40 | 26,720 | 13.65% | 5,242 | 73.90 |
| Lupin | 104,535 | 19.46 | 27,488 | 19.98% | 5,345 | 48.15 |
| Mankind Pharma | 101,447 | 52.84 | 14,278 | 12.03% | 1,750 | 59.66 |
| Aurobindo Pharma | 84,483 | 24.29 | 33,385 | 3.21% | 3,376 | 51.11 |
| Laurus Labs | 73,221 | 81.46 | 6,813 | 21.03% | 884 | 78.36 |
Ind Swift Laboratories Company Announcements - News Screener
Screen INDSWFTLAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-05-25 | Board Meeting Intimation for Meeting To Be Held On May 28 2026. | - |
| 2026-05-18 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | - |
| 2026-05-05 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-04-22 | Disclosures Under Regulation 29(2) Of The SEBI (Substantial Acquisition Of Shares And Takeover) Regulations 2011 | - |
| 2026-04-21 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-04-09 | Clarification On Spurt In Volume | - |
| 2026-04-09 | Clarification sought from Ind-Swift Laboratories Ltd | - |
| 2026-04-07 | Intimation Of Receipt Of Arbitration Award | - |
| 2026-04-06 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-04-03 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-31 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | - |
| 2026-03-31 | Closure of Trading Window | - |
| 2026-03-31 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-03-30 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | - |
| 2026-03-27 | Board Meeting Outcome for Outcome Of Board Meeting Held On March 27 2026 | - |
| 2026-03-02 | Intimation Regarding Ecovadis Silver Medal And Global Certification | - |
| 2026-03-01 | Lapse Of 6500000 Fully Convertible Warrants And Forfeiture Of Upfront Amount | - |
| 2026-02-27 | Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-02-27 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-02-26 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |